REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector. read more
Mark Murphy ā Vice President, Finance at REGENXBIO
Executive Bio
Mark Murphy serves as the Vice President, Finance of REGENXBIO Inc.. Mark started at REGENXBIO Inc. in March of 2018. Mark currently resides in Washington D.C. Metro Area.
Executive Team Culture Ratings from REGENXBIO Employees
BOTTOM
25%
REGENXBIO's Executive Team scores in the Bottom 25%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at REGENXBIONot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at REGENXBIOREGENXBIO's Executive Team at a Glance
Based on 10 ratings, REGENXBIO's employees are less satisfied with their Executive Team and give them a āD+ā or 61/100.
REGENXBIO's Executive Team ranks in the Bottom 30% of other companies in Washington, DC and Bottom 25% of other companies on Comparably that also have 1-10 Employees.
×